Medindia LOGIN REGISTER
Medindia

Metronidazole Interaction with other Drugs


Metronidazole is an antibacterial agent, prescribed for trichomoniasis, amebiasis and other bacterial infections.

Metronidazole Interaction with 219 drugs. Find out more in the list below:

Abiraterone


The metabolism of Metronidazole can be decreased when combined with Abiraterone.

Acenocoumarol


The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.

Amiodarone


The metabolism of Metronidazole can be decreased when combined with Amiodarone.

Advertisement

Amodiaquine


The serum concentration of Amodiaquine can be increased when it is combined with Metronidazole.

Anagrelide


Metronidazole may increase the QTc-prolonging activities of Anagrelide.

Apalutamide


The serum concentration of Metronidazole can be decreased when it is combined with Apalutamide.

Advertisement

Aprepitant


The serum concentration of Metronidazole can be increased when it is combined with Aprepitant.

Arsenic Trioxide


Metronidazole may increase the QTc-prolonging activities of Arsenic trioxide.

Artemether


Metronidazole may increase the QTc-prolonging activities of Artemether.

Advertisement

Asenapine


Metronidazole may increase the QTc-prolonging activities of Asenapine.

Atazanavir


The metabolism of Metronidazole can be decreased when combined with Atazanavir.

Atomoxetine


The metabolism of Metronidazole can be decreased when combined with Atomoxetine.

Atorvastatin


The risk or severity of adverse effects can be increased when Metronidazole is combined with Atorvastatin.

Azithromycin


Metronidazole may increase the QTc-prolonging activities of Azithromycin.

Bedaquiline


Metronidazole may increase the QTc-prolonging activities of Bedaquiline.

Boceprevir


The metabolism of Metronidazole can be decreased when combined with Boceprevir.

Bortezomib


The metabolism of Metronidazole can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Metronidazole can be decreased when it is combined with Bosentan.

Bosutinib


The serum concentration of Bosutinib can be increased when it is combined with Metronidazole.

Bosutinib monohydrate


The serum concentration of Bosutinib can be increased when it is combined with Metronidazole.

Bromocriptine


The risk or severity of adverse effects can be increased when Bromocriptine is combined with Metronidazole.

Busulfan


The serum concentration of Busulfan can be increased when it is combined with Metronidazole.

Cabergoline


The risk or severity of adverse effects can be increased when Cabergoline is combined with Metronidazole.

Capecitabine


The serum concentration of the active metabolites of Capecitabine can be increased when Capecitabine is used in combination with Metronidazole.

Carbamazepine


The metabolism of Metronidazole can be increased when combined with Carbamazepine.

Carbocysteine


The risk or severity of adverse effects can be increased when Metronidazole is combined with Carbocisteine.

Ceritinib


The serum concentration of Metronidazole can be increased when it is combined with Ceritinib.

Cerivastatin


The serum concentration of Cerivastatin can be increased when it is combined with Metronidazole.

Chloroquine


Metronidazole may increase the QTc-prolonging activities of Chloroquine.

Chlorpromazine


Metronidazole may increase the QTc-prolonging activities of Chlorpromazine.

Cholecalciferol


The metabolism of Metronidazole can be decreased when combined with Cholecalciferol.

Ciprofloxacin


Metronidazole may increase the QTc-prolonging activities of Ciprofloxacin.

Cisapride


Metronidazole may increase the QTc-prolonging activities of Cisapride.

Citalopram


Metronidazole may increase the QTc-prolonging activities of Citalopram.

Clarithromycin


The metabolism of Metronidazole can be decreased when combined with Clarithromycin.

Clemastine


The metabolism of Metronidazole can be decreased when combined with Clemastine.

Clotrimazole


The metabolism of Metronidazole can be decreased when combined with Clotrimazole.

Clozapine


Metronidazole may increase the QTc-prolonging activities of Clozapine.

Cobicistat


The metabolism of Metronidazole can be decreased when combined with Cobicistat.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Metronidazole.

Crisaborole


The metabolism of Metronidazole can be decreased when combined with Crisaborole.

Crizotinib


The metabolism of Metronidazole can be decreased when combined with Crizotinib.

Cyclosporine


The metabolism of Metronidazole can be decreased when combined with Cyclosporine.

Dabrafenib


The serum concentration of Metronidazole can be decreased when it is combined with Dabrafenib.

Darunavir


The metabolism of Metronidazole can be decreased when combined with Darunavir.

Dasatinib


The serum concentration of Metronidazole can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Metronidazole can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Metronidazole can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Metronidazole can be decreased when combined with Delavirdine.

Dicumarol


The serum concentration of Dicoumarol can be increased when it is combined with Metronidazole.

Dihydroergotamine


The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Metronidazole.

Diltiazem


The metabolism of Metronidazole can be decreased when combined with Diltiazem.

Disopyramide


Metronidazole may increase the QTc-prolonging activities of Disopyramide.

Disulfiram


The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.

Dofetilide


Metronidazole may increase the QTc-prolonging activities of Dofetilide.

Dolasetron


Metronidazole may increase the QTc-prolonging activities of Dolasetron.

Domperidone


Metronidazole may increase the QTc-prolonging activities of Domperidone.

Dothiepin


The metabolism of Metronidazole can be decreased when combined with Dosulepin.

Doxycycline


The metabolism of Metronidazole can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Metronidazole can be decreased when combined with Doxycycline.

Dronedarone


Metronidazole may increase the QTc-prolonging activities of Dronedarone.

Droperidol


Metronidazole may increase the QTc-prolonging activities of Droperidol.

Efavirenz


The metabolism of Metronidazole can be decreased when combined with Efavirenz.

Eliglustat


Metronidazole may increase the QTc-prolonging activities of Eliglustat.

Enzalutamide


The serum concentration of Metronidazole can be decreased when it is combined with Enzalutamide.

Ergonovine


The risk or severity of adverse effects can be increased when Ergonovine is combined with Metronidazole.

Ergotamine


The risk or severity of adverse effects can be increased when Ergotamine is combined with Metronidazole.

Erythromycin


The metabolism of Metronidazole can be decreased when combined with Erythromycin.

Escitalopram


Metronidazole may increase the QTc-prolonging activities of Escitalopram.

Ethanol


The risk or severity of adverse effects can be increased when Metronidazole is combined with Ethanol.

Etravirine


The metabolism of Metronidazole can be decreased when combined with Etravirine.

Flecainide


Metronidazole may increase the QTc-prolonging activities of Flecainide.

Floxuridine


The metabolism of Metronidazole can be decreased when combined with Floxuridine.

Fluconazole


The metabolism of Metronidazole can be decreased when combined with Fluconazole.

Fluindione


The serum concentration of Fluindione can be increased when it is combined with Metronidazole.

Fluorouracil


The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.

Fluoxetine


Metronidazole may increase the QTc-prolonging activities of Fluoxetine.

Flupenthixol


Metronidazole may increase the QTc-prolonging activities of Flupentixol.

Fluvastatin


The serum concentration of Fluvastatin can be increased when it is combined with Metronidazole.

Fluvoxamine


The metabolism of Metronidazole can be decreased when combined with Fluvoxamine.

Fosamprenavir


The metabolism of Metronidazole can be decreased when combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Metronidazole can be increased when it is combined with Fosaprepitant.

Fosphenytoin


The serum concentration of Metronidazole can be decreased when it is combined with Fosphenytoin.

Fusidate


The serum concentration of Metronidazole can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Metronidazole can be increased when it is combined with Fusidic Acid.

Gadobenate


Metronidazole may increase the QTc-prolonging activities of Gadobenic acid.

Gemfibrozil


The metabolism of Metronidazole can be decreased when combined with Gemfibrozil.

Gemifloxacin


Metronidazole may increase the QTc-prolonging activities of Gemifloxacin.

Gemifloxacin Mesylate


Metronidazole may increase the QTc-prolonging activities of Gemifloxacin.

Goserelin


Metronidazole may increase the QTc-prolonging activities of Goserelin.

Granisetron


Metronidazole may increase the QTc-prolonging activities of Granisetron.

Haloperidol


Metronidazole may increase the QTc-prolonging activities of Haloperidol.

Hypoxis hemerocallidea root extract


The serum concentration of Metronidazole can be decreased when it is combined with St. John's Wort.

Ibrutinib


The serum concentration of Ibrutinib can be increased when it is combined with Metronidazole.

Ibutilide


Metronidazole may increase the QTc-prolonging activities of Ibutilide.

Idelalisib


The metabolism of Metronidazole can be decreased when combined with Idelalisib.

Iloperidone


Metronidazole may increase the QTc-prolonging activities of Iloperidone.

Imatinib


The metabolism of Metronidazole can be decreased when combined with Imatinib.

Indinavir


The metabolism of Metronidazole can be decreased when combined with Indinavir.

INDINAVIR ANHYDROUS


The metabolism of Metronidazole can be decreased when combined with Indinavir.

Irbesartan


The metabolism of Metronidazole can be decreased when combined with Irbesartan.

Isavuconazole


The serum concentration of Metronidazole can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Metronidazole can be decreased when combined with Isavuconazonium.

Isradipine


The metabolism of Metronidazole can be decreased when combined with Isradipine.

Itraconazole


The metabolism of Metronidazole can be decreased when combined with Itraconazole.

Ivacaftor


The serum concentration of Metronidazole can be increased when it is combined with Ivacaftor.

Ketoconazole


The metabolism of Metronidazole can be decreased when combined with Ketoconazole.

Leflunomide


The metabolism of Metronidazole can be decreased when combined with Leflunomide.

Lenvatinib


Metronidazole may increase the QTc-prolonging activities of Lenvatinib.

Lenvatinib Mesylate


Metronidazole may increase the QTc-prolonging activities of Lenvatinib.

Leuprolide


Metronidazole may increase the QTc-prolonging activities of Leuprolide.

Levofloxacin


Metronidazole may increase the QTc-prolonging activities of Levofloxacin.

Levofloxacin Anhydrous


Metronidazole may increase the QTc-prolonging activities of Levofloxacin.

Lisuride


The risk or severity of adverse effects can be increased when Lisuride is combined with Metronidazole.

Lopinavir


The risk or severity of adverse effects can be increased when Metronidazole is combined with Lopinavir.

Losartan


The metabolism of Metronidazole can be decreased when combined with Losartan.

Lovastatin


The serum concentration of Lovastatin can be increased when it is combined with Metronidazole.

Luliconazole


The serum concentration of Metronidazole can be increased when it is combined with Luliconazole.

Lumacaftor


The serum concentration of Metronidazole can be decreased when it is combined with Lumacaftor.

Lumefantrine


Metronidazole may increase the QTc-prolonging activities of Lumefantrine.

Manidipine


The metabolism of Metronidazole can be decreased when combined with Manidipine.

Mebendazole


The risk or severity of adverse effects can be increased when Mebendazole is combined with Metronidazole.

Metergoline


The risk or severity of adverse effects can be increased when Metergoline is combined with Metronidazole.

Methadone


Metronidazole may increase the QTc-prolonging activities of Methadone.

Methylergonovine


The risk or severity of adverse effects can be increased when Methylergometrine is combined with Metronidazole.

Methysergide


The risk or severity of adverse effects can be increased when Methysergide is combined with Metronidazole.

Midostaurin


The metabolism of Metronidazole can be decreased when combined with Midostaurin.

Mifepristone


The serum concentration of Metronidazole can be increased when it is combined with Mifepristone.

Mitotane


The serum concentration of Metronidazole can be decreased when it is combined with Mitotane.

Moxifloxacin


Metronidazole may increase the QTc-prolonging activities of Moxifloxacin.

MYCOPHENOLATE


The serum concentration of Mycophenolic acid can be decreased when it is combined with Metronidazole.

Mycophenolic Acid


The serum concentration of Mycophenolic acid can be decreased when it is combined with Metronidazole.

Nefazodone


The metabolism of Metronidazole can be decreased when combined with Nefazodone.

Nelfinavir


The metabolism of Metronidazole can be decreased when combined with Nelfinavir.

Netupitant


The serum concentration of Metronidazole can be increased when it is combined with Netupitant.

Nevirapine


The metabolism of Metronidazole can be increased when combined with Nevirapine.

Nicardipine


The metabolism of Metronidazole can be decreased when combined with Nicardipine.

Nicergoline


The risk or severity of adverse effects can be increased when Nicergoline is combined with Metronidazole.

Nilotinib


Metronidazole may increase the QTc-prolonging activities of Nilotinib.

Ofloxacin


Metronidazole may increase the QTc-prolonging activities of Ofloxacin.

Olaparib


The metabolism of Metronidazole can be decreased when combined with Olaparib.

Omeprazole


The metabolism of Metronidazole can be decreased when combined with Omeprazole.

Ondansetron


Metronidazole may increase the QTc-prolonging activities of Ondansetron.

Osimertinib


The serum concentration of Metronidazole can be increased when it is combined with Osimertinib.

Palbociclib


The serum concentration of Metronidazole can be increased when it is combined with Palbociclib.

Paliperidone


Metronidazole may increase the QTc-prolonging activities of Paliperidone.

Panobinostat


Metronidazole may increase the QTc-prolonging activities of Panobinostat.

Pazopanib


Metronidazole may increase the QTc-prolonging activities of Pazopanib.

Pentamidine


Metronidazole may increase the QTc-prolonging activities of Pentamidine.

Pentobarbital


The metabolism of Metronidazole can be increased when combined with Pentobarbital.

Perflutren


Metronidazole may increase the QTc-prolonging activities of Perflutren.

Pergolide


The risk or severity of adverse effects can be increased when Pergolide is combined with Metronidazole.

Phenindione


The serum concentration of Phenindione can be increased when it is combined with Metronidazole.

Phenobarbital


The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.

Phenprocoumon


The serum concentration of Phenprocoumon can be increased when it is combined with Metronidazole.

Phenytoin


The serum concentration of Metronidazole can be decreased when it is combined with Phenytoin.

Picosulfuric Acid


The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Metronidazole.

Pimozide


Metronidazole may increase the QTc-prolonging activities of Pimozide.

Pitavastatin


The serum concentration of Pitavastatin can be increased when it is combined with Metronidazole.

Posaconazole


The metabolism of Metronidazole can be decreased when combined with Posaconazole.

Pravastatin


The serum concentration of Pravastatin can be increased when it is combined with Metronidazole.

Primaquine


Metronidazole may increase the QTc-prolonging activities of Primaquine.

Primidone


The serum concentration of Metronidazole can be decreased when it is combined with Primidone.

Procainamide


Metronidazole may increase the QTc-prolonging activities of Procainamide.

Promazine


Metronidazole may increase the QTc-prolonging activities of Promazine.

Propafenone


Metronidazole may increase the QTc-prolonging activities of Propafenone.

Pyrimethamine


The metabolism of Metronidazole can be decreased when combined with Pyrimethamine.

Quetiapine


Metronidazole may increase the QTc-prolonging activities of Quetiapine.

Quetiapine fumarate


Metronidazole may increase the QTc-prolonging activities of Quetiapine.

Quinidine


Metronidazole may increase the QTc-prolonging activities of Quinidine.

Quinine


Metronidazole may increase the QTc-prolonging activities of Quinine.

Ranolazine


The metabolism of Metronidazole can be decreased when combined with Ranolazine.

Rifabutin


The metabolism of Metronidazole can be increased when combined with Rifabutin.

Rifampin


The metabolism of Metronidazole can be increased when combined with Rifampicin.

Rifapentine


The metabolism of Metronidazole can be increased when combined with Rifapentine.

Rilpivirine


The serum concentration of Rilpivirine can be increased when it is combined with Metronidazole.

Ritonavir


The risk or severity of adverse effects can be increased when Ritonavir is combined with Metronidazole.

Rosuvastatin


The serum concentration of Rosuvastatin can be increased when it is combined with Metronidazole.

Rucaparib


The metabolism of Metronidazole can be decreased when combined with Rucaparib.

Saquinavir


The metabolism of Metronidazole can be decreased when combined with Saquinavir.

Saquinavir Mesylate


The metabolism of Metronidazole can be decreased when combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Metronidazole can be decreased when used in combination with Sarilumab.

Secobarbital


The metabolism of Metronidazole can be increased when combined with Secobarbital.

Sildenafil


The metabolism of Metronidazole can be decreased when combined with Sildenafil.

Siltuximab


The serum concentration of Metronidazole can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Metronidazole can be increased when it is combined with Simeprevir.

Simvastatin


The serum concentration of Simvastatin can be increased when it is combined with Metronidazole.

Sorafenib


The metabolism of Metronidazole can be decreased when combined with Sorafenib.

Sotalol


Metronidazole may increase the QTc-prolonging activities of Sotalol.

ST. JOHN'S WORT EXTRACT


The serum concentration of Metronidazole can be decreased when it is combined with St. John's Wort.

Sulfadiazine


The metabolism of Metronidazole can be decreased when combined with Sulfadiazine.

Sulfamethoxazole


The metabolism of Metronidazole can be decreased when combined with Sulfamethoxazole.

Sulfisoxazole


The metabolism of Metronidazole can be decreased when combined with Sulfisoxazole.

Tegafur


The serum concentration of the active metabolites of Tegafur can be increased when Tegafur is used in combination with Metronidazole.

Telaprevir


The metabolism of Metronidazole can be decreased when combined with Telaprevir.

Telavancin


Metronidazole may increase the QTc-prolonging activities of Telavancin.

Telithromycin


The metabolism of Metronidazole can be decreased when combined with Telithromycin.

Tetrabenazine


Metronidazole may increase the QTc-prolonging activities of Tetrabenazine.

Thioridazine


Metronidazole may increase the QTc-prolonging activities of Thioridazine.

Ticagrelor


The metabolism of Metronidazole can be decreased when combined with Ticagrelor.

Ticlopidine


The metabolism of Metronidazole can be decreased when combined with Ticlopidine.

Tipranavir


The risk or severity of adverse effects can be increased when Metronidazole is combined with Tipranavir.

Tocilizumab


The serum concentration of Metronidazole can be decreased when it is combined with Tocilizumab.

Tolbutamide


The metabolism of Metronidazole can be decreased when combined with Tolbutamide.

Tolvaptan


The serum concentration of Tolvaptan can be increased when it is combined with Metronidazole.

Toremifene


Metronidazole may increase the QTc-prolonging activities of Toremifene.

Trimethoprim


The metabolism of Metronidazole can be decreased when combined with Trimethoprim.

Valproate


The metabolism of Metronidazole can be decreased when combined with Valproic Acid.

Valproic Acid


The metabolism of Metronidazole can be decreased when combined with Valproic Acid.

Valsartan


The metabolism of Metronidazole can be decreased when combined with Valsartan.

Vandetanib


Metronidazole may increase the QTc-prolonging activities of Vandetanib.

Vemurafenib


The serum concentration of Metronidazole can be decreased when it is combined with Vemurafenib.

Venlafaxine


The metabolism of Metronidazole can be decreased when combined with Venlafaxine.

Verapamil


The metabolism of Metronidazole can be decreased when combined with Verapamil.

Voriconazole


The metabolism of Metronidazole can be decreased when combined with Voriconazole.

Warfarin


The serum concentration of Warfarin can be increased when it is combined with Metronidazole.

Zafirlukast


The metabolism of Metronidazole can be decreased when combined with Zafirlukast.

Ziprasidone


Metronidazole may increase the QTc-prolonging activities of Ziprasidone.

Zuclopenthixol


Metronidazole may increase the QTc-prolonging activities of Zuclopenthixol.

Advertisement
Recommended Reading
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
How to Live Longer and Healthier: Secrets of Longevity Revealed
Stay Connected
Available on the Android Market Available on the App Store
Advertisement
Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional